Bottomline: Affirma-backed nutraceuticals maker Tirupati's financial see-saw continues

Premium

Nutraceuticals maker Tirupati Medicare recorded a hit in operational margin in FY23 after fluctuations last fiscal, even as the company’s outlook is expected to be stable in the medium term, it is learnt. The Himachal Pradesh-based company's EBITDA margins hovered within the range of 10-12% in the recent past but faced ......